Impact News +++ PayPal Partners with Tenpay/ Others to Establish Global Digital Wallet Platform (AAStocks) +++ TENCENT Aktie +3,98%

MEMPHASYS Aktie

>MEMPHASYS Performance

1 Woche: 0%

1 Monat: 0%

3 Monate: -16,7%

6 Monate: -44,4%

1 Jahr: -44,4%

laufendes Jahr: -28,6%

>MEMPHASYS Aktie

Name:

MEMPHASYS LTD

Land:

Australien

Sektor:

Gesundheit

ISIN/ Wkn:

AU000000MEM5 / A2ANGR

Symbol/ Ticker:

IG7 (Frankfurt)

Kürzel:

FRA:IG7, ETR:IG7, IG7:GR

Index:

Webseite:

http://www.memphasys.com/

Marktkapitalisierung:

5.5 Mio. EUR

Umsatz:

0.01 Mio. EUR

EBITDA:

-2.2 Mio. EUR

Gewinn je Aktie:

Schulden:

2.26 Mio. EUR

Liquide Mittel:

0.27 Mio. EUR

Umsatz-/ Gewinnwachstum:

-43.02% / -9.42%

KGV/ KGV lG:

- / -

KUV/ KBV/ PEG:

201.32 / 0.98 / -

Gewinnm./ Eigenkapitalr.:

-18434.74% / -80.47%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

MEMPHASYS

Letzte Datenerhebung:

23.07.25

>MEMPHASYS Eigentümer

Aktien: 1983.6 Mio. St.

f.h. Aktien: 1100 Mio. St.

Insider Eigner: 44.61%

Instit. Eigner: 0.47%

Leerverk. Aktien: -

>MEMPHASYS Peer Group

ACRUX

BPH GLOBAL

CANN GROUP

INVION

MONASH IVF

RHYTHM BIOSCIENCES

SOMNOMED

STARPHARMA

STRUCTURAL MONITORING

SYNTARA

>MEMPHASYS Chart & Kurs - Stuttgart

>MEMPHASYS News

08.05.25 - 05:12

Memphasys pilot study confirms RoXsta′s potential as high-throughput antioxidant diagnostic tool (Small Caps)

A pilot study has shown that Memphasys' (ASX: MEM) RoXsta Mega Cell high-throughput assay device can conduct large-scale, simultaneous antioxidant assays within a lab setting. The study demonstrated that the next-generation analytical platform was able to process 96 samples in less than one hour, returning highly accurate antioxidant readings for individuals requiring antioxidant therapy. The […] The post Memphasys pilot study confirms RoXsta's potential as high-throughput antioxidant diagnostic tool appeared first on Small Caps....

14.04.25 - 09:06	XFRA: IG7: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN MEMPHASYS LTD IG7 AU000000MEM5 AB/FROM ONWARDS 14.04.2025...

10.04.25 - 07:51	XFRA: IG7: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL MEMPHASYS LTD IG7 AU000000MEM5 BAW/UFN...

10.04.25 - 07:46	XFRA: INSTRUMENT_SUSPENSION - AU000000MEM5 (XETRA)
	Instrument ID [1729] (IG7 - AU000000MEM5) suspended...

24.03.25 - 08:31	XFRA : IG7: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN MEMPHASYS LTD IG7 AU000000MEM5 AB/FROM ONWARDS 24.03.2025 08:14 CET...

24.03.25 - 05:12

Memphasys achieves key milestone with clinical validation of Felix fertility device (Small Caps)

Memphasys (ASX: MEM) has published positive data from a pivotal clinical trial of its Felix electrophoresis-based sperm separation device for use in assisted reproduction. The trial validated the ability of the Felix device to meet and exceed industry benchmarks and found it to be non-inferior to the “swim-up” technique but statistically superior to DGC (density-gradient […] The post Memphasys achieves key milestone with clinical validation of Felix fertility device appeared first on Small Caps....

24.03.25 - 03:24	Monday′s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results \| March 21, 2025 (Market Herald)
	The ASX has been trading flat at around 7,928 points. Discretionary has…...

24.03.25 - 00:12	Memphasys tech: Trial results prove it lifts the guys’ game in IVF (Market Herald)
	Reproductive technology developed by Memphasys (ASX:MEM) is proving to be a gamechanger…...

20.03.25 - 08:01	XFRA : IG7: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL MEMPHASYS LTD IG7 AU000000MEM5 BAW/UFN...

20.03.25 - 07:54	XFRA : INSTRUMENT_SUSPENSION - AU000000MEM5 (XETRA)
	Instrument ID [1729] (IG7 - AU000000MEM5) suspended...

16.01.25 - 00:36	Publication highlights strengths of Memphasys’ antioxidant profiling system (Market Herald)
	Memphasys Ltd (ASX:MEM) has seen a boost to its proprietary antioxidant profiling…...

05.12.24 - 03:43	Sperm tech player Memphasys ships unit to Dubai – but can the stock attract liquidity? (Market Herald)
	Biotech nanocap Memphasys (ASX:MEM) has sent a demo unit of its Felix…...

12.09.24 - 08:37	XFRA : IG7: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN MEMPHASYS LTD IG7 AU000000MEM5 AB/FROM ONWARDS 12.09.2024 08:31 CET...

09.09.24 - 08:32	XFRA : IG7: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL MEMPHASYS LTD IG7 AU000000MEM5 BAW/UFN...

09.09.24 - 07:56	XFRA : INSTRUMENT_SUSPENSION - AU000000MEM5 (XETRA)
	Instrument ID [1729] (IG7 - AU000000MEM5) suspended...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Ein Politiker verschweigt oft auch das, was er nicht weiß. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram